Significance of mucin-suspended tumor bud-like structures in colorectal cancer
Äijälä, Ville K.; Sirniö, Päivi; Elomaa, Hanna; Karjalainen, Henna; Kastinen, Meeri; Tapiainen, Vilja V.; Ahtiainen, Maarit; Helminen, Olli; Wirta, Erkki Ville; Rintala, Jukka; Meriläinen, Sanna; Saarnio, Juha; Rautio, Tero; Seppälä, Toni T.; Böhm, Jan; Mecklin, Jukka Pekka; Tuomisto, Anne; Mäkinen, Markus J.; Väyrynen, Juha P. (2025-04)
Äijälä, Ville K.
Sirniö, Päivi
Elomaa, Hanna
Karjalainen, Henna
Kastinen, Meeri
Tapiainen, Vilja V.
Ahtiainen, Maarit
Helminen, Olli
Wirta, Erkki Ville
Rintala, Jukka
Meriläinen, Sanna
Saarnio, Juha
Rautio, Tero
Seppälä, Toni T.
Böhm, Jan
Mecklin, Jukka Pekka
Tuomisto, Anne
Mäkinen, Markus J.
Väyrynen, Juha P.
04 / 2025
HUMAN PATHOLOGY
105772
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202505085042
https://urn.fi/URN:NBN:fi:tuni-202505085042
Kuvaus
Peer reviewed
Tiivistelmä
Tumor budding (TB) is an independent predictor of adverse prognosis in colorectal cancer (CRC), defined as clusters of fewer than 5 tumor cells at the invasive margin of cancer. According to the international consensus criteria (ITBCC), TB should be evaluated from the non-mucinous regions. However, some tumors also contain tumor bud-like structures within extracellular mucin pools, and the prognostic impact of these structures remains unclear. To assess this, we defined a modified tumor budding variable (TB-Muc), representing the highest number of tumor buds/bud-like structures observed in a hotspot (0.785 mm2) at the invasive margin, including extracellular mucin regions. We analyzed the prognostic significance of TB (ITBCC criteria) and TB-Muc in two CRC cohorts (N = 1876). TB-ITBCC was associated with advanced stage and lymphovascular invasion (p < 0.001) but also with shorter cancer-specific survival independent of other prognostic factors (Cohort 1: HR for high vs. low 1.99, 95 % CI 1.32–3.01, ptrend = 0.0007; Cohort 2: HR 1.35, 95 % CI 0.98–1.85, ptrend = 0.037). TB-Muc had a comparable independent association with shorter cancer-specific survival (Cohort 1: HR for high vs. low 1.77, 95 % CI 1.18–2.65, ptrend = 0.006; Cohort 2: HR 1.39, 95 % CI 1.02–1.89, ptrend = 0.019). Our results indicate that tumor bud-like structures in mucin do not provide additional prognostic value and should not be included in TB evaluation.
Kokoelmat
- TUNICRIS-julkaisut [20263]